Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,262
Closed -$625K 515
2026
Q1
$625K Sell
8,262
-113
-1% -$8.5K 0.03% 379
2025
Q4
$624K Sell
8,375
-453
-5% -$33.1K 0.03% 376
2025
Q3
$596K Buy
8,828
+76
+0.9% +$5.04K 0.03% 400
2025
Q2
$570K Buy
8,752
+49
+0.6% +$2.94K 0.03% 406
2025
Q1
$538K Buy
8,703
+334
+4% +$22.1K 0.03% 394
2024
Q4
$603K Sell
8,369
-104
-1% -$8.13K 0.03% 369
2024
Q3
$690K Buy
8,473
+147
+2% +$11.8K 0.04% 349
2024
Q2
$618K Sell
8,326
-777
-9% -$58.2K 0.04% 349
2024
Q1
$710K Buy
9,103
+283
+3% +$21.1K 0.04% 343
2023
Q4
$630K Buy
8,820
+53
+0.6% +$3.69K 0.04% 352
2023
Q3
$608K Buy
8,767
+786
+10% +$59.4K 0.04% 332
2023
Q2
$646K Sell
7,981
-5,537
-41% -$452K 0.05% 312
2023
Q1
$1.09M Buy
13,518
+321
+2% +$25.8K 0.1% 191
2022
Q4
$987K Buy
13,197
+588
+5% +$41.9K 0.1% 202
2022
Q3
$814K Sell
12,609
-5,540
-31% -$384K 0.1% 198
2022
Q2
$1.26M Buy
18,149
+53
+0.3% +$3.93K 0.16% 125
2022
Q1
$1.39M Buy
18,096
+531
+3% +$38.2K 0.16% 122
2021
Q4
$1.34M Sell
17,565
-6,599
-27% -$485K 0.16% 121
2021
Q3
$1.78M Buy
24,164
+8,768
+57% +$658K 0.27% 72
2021
Q2
$1.03M Buy
+15,396
New +$1.03M 0.17% 132

Other funds holding HOLX

Empirical Finance's HOLX Position: Q2 2026 in Review

Empirical Finance sold out of Hologic (HOLX) in Q2 2026, closing a stake of 8,262 shares — an estimated $625K sold.

Empirical Finance first reported a position in HOLX in Q2 2021 and held it in 20 quarters. The position peaked at $1.78M in Q3 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Empirical Finance reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Empirical Finance sold 8,262 Hologic shares in Q2 2026, an estimated $625K.
  • Empirical Finance first reported a position in Hologic in Q2 2021 and held it in 20 quarters.
  • Empirical Finance's Hologic position peaked at $1.78M in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Empirical Finance's 13F filing for Q2 2026, filed 14 Aug 2026.